Full Length Research Paper
References
|
Agouni A, Lagrue-Lak-Hal A, Mostefai HA, Tesse A, Mulder P, Rouet P (2009). Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS ONE 4(5):1-8. |
|
|
American Diabetes Association (2008). Diagnosis and classi?cation of diabetes mellitus. Diabetes Care 31(1):62-67. |
|
|
Bardini G, Rotella CM, Giannini S (2012). Dyslipidemia and Diabetes: Reciprocal Impact of Impaired Lipid Metabolism and Beta-Cell Dysfunction on Micro- and Macrovascular Complications. The Review of Diabetic Studies 9:2-3. |
|
|
Cotrozzi G, Casini Raggi V, Relli P, Buzzelli G (1997). Role of the liver in the regulation of glucose metabolism in diabetes and chronic liver disease. Annali Italiani di Medicina Interna 12(2):84-91. |
|
|
Dej-adisai S, Pitakbut T (2015). Determination of α-glucosidase inhibitory activity from selected Fabaceae plants. Pakistan Journal of Pharmaceutical Sciences 28(5):1679-1683. |
|
|
Jiang YH, Sun W, Li W, Hu HZ, Zhou L, Jiang HH (2015). Calycosin-7-O-β-D-glucoside promotes oxidative stress-induced cytoskeleton reorganization through integrin-linked kinase signaling pathway in vascular endothelial cells. BMC Complementary and Alternative Medicine 15(315):1-11. |
|
|
Kamagaté M, Koffi C, Kouamé NM, Akoubet A, Yao NAR, Die-Kakou HM (2014). Ethnobotany, phytochemistry, pharmacology and toxicology profiles of Cassia siamea Lam. The Journal of Phytopharmacology 3(1):57-76. |
|
|
Khavandi K, Amer H, Ibrahim B, Brownrigg J (2013). Strategies for pre-venting type 2 diabetes: an update for clinicians. Therapeutic Advances in Chronic Disease 4:242-261. |
|
|
Kim HJ, Park KS, Lee SK, Min KW, Han KA, Kim YKl (2012). Effects of pinitol on glycemic control, insulin resistance and adipocytokine levels in patients with type 2 diabetes mellitus. The Annals of Nutrition and Metabolism 60(1):1-5. |
|
|
King A (2012). The use of animal models in diabetes research. British Journal of Pharmacology 166:877-894. |
|
|
Koffi C, Kamagaté M, Koffi E, Kouamé NM, Yao NAR, Balayssac E, Die-Kakou HM (2016). Aqueous extract of leaves of Cassia siamea Lam exhibited antihyperglycemic effect and improved kidney function in diabetic Wistar rats. International Journal of Pharmaceutical Research 6(11):336-342. |
|
|
Koffi C, Kouame NM, N'zoue KS, Yobo BMS, Kee MYC, Toure M, Kamagate M (2022). Inhibitory effect of Cassia siamea methanol extract on intestinal glucose absorption in glucose-induced hyperglycemic Wistar rats. West African Journal of Pharmacology and Drug Research 36:62-66. |
|
|
Koffi C, Soleti R, Nitiema M, Mallegol P, Hilairet G, Chaigneau J (2019). Ethanol Extract of Leaves of Cassia siamea Lam Protects against Diabetes-Induced Insulin Resistance, Hepatic, and Endothelial Dysfunctions in ob/ob Mice. Oxidative Medicine and Cellular Longevity 2019, ID 6560498: 1-11. |
|
|
Kumar D, Karmase A, Jagtap S, Shekhar R, Bhutani KK (2013). Pancreatic lipase inhibitory activity of cassiamin A, a bianthraquinone from Cassia siamea. Natural Product Communications 8:195-198. |
|
|
Kumar S, Kumar V, Prakash OM (2010). Antidiabetic and anti-lipemic effects of Cassia siamea leaves extract in streptozotocin induced diabetic rats. Journal of Tropical Medicine 3(11):871-873. |
|
|
Lima CR, Vasconcelosa CFB, Costa-Silvab JH, Maranhãoc CA, Costad J, Batistae TM (2012). Anti-diabetic activity of extract from Persea americana Mill. leaf via the activation of protein kinase B (PKB/Akt) in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 141(1):517-525. |
|
|
Luangpirom A, Saenbuaphan N (2006). Hypoglycemic effect of Senna siamea (Lam.) leaf extract in rats. KKU Research Journal 11:77-83 |
|
|
Lucchesi AN, Cassettari LL, Spadella CT (2015). Alloxan-Induced Diabetes Causes Morphological and Ultrastructural Changes in Rat Liver that Resemble the Natural History of Chronic Fatty Liver Disease in Humans. Journal of Diabetes Research ID 494578:1-11. |
|
|
McCall AL (2012). Insulin Therapy and Hypoglycemia. Endocrinology and Metabolism Clinics of North America 41(1):57-87. |
|
|
McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. British Journal of Pharmacology 160:1573-1576. |
|
|
Mohammed A, Atiku MK (2012). Antihyperglycemic and antihyperglycemic effects of leaves and stem bark methanol extracts Cassia siamea in alloxan-induced diabetic rats. Current Research in Cardiovascular Pharmacology 1(1):10-17. |
|
|
Moradabadi L, Montasser KS, Fehresti SM (2013). Hypoglycemic Effects of Three Medicinal Plants in Experimental Diabetes: Inhibition of Rat Intestinal α-glucosidase and Enhanced Pancreatic Insulin and Cardiac Glut-4 mRNAs Expression. Iranian Journal of Pharmaceutical Research 12(3):387-397. |
|
|
Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI (1994). On the pathogenesis of IDDM. Diabetologia 37(2):82-89. |
|
|
Nuankaew W, Heemman A, Wattanapiromsakul C, Shim JH, Kim NW, Yasmin T, Jeong SY (2021). Anti-insulin resistance effect of constituents from Senna siamea on zebrafish model, its molecular docking, and structure-activity relationships. Journal of Natural Medicines 75(3):520-531. |
|
|
OECD/OCDE 423 (2001). OECD guideline for testing of chemicals. Acute oral toxicity - acute toxic class method. 14 p. |
|
|
Shafiullah PM, Kamil MA (1995). New isoflavone C-glycoside from Cassia siamea. Fitoterapia 66:439-441. |
|
|
Standl E, Schnell O (2012). Alpha-glucosidase inhibitors: cardiovascular considerations and trial evaluation. Diabetes and Vascular Disease Research 9:163-169. |
|
|
Szkudelski T (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research 50:537-546. |
|
|
Tanty H, Permai SD, Pudjihastuti H (2018). In vivo anti-diabetic activity test of ethanol extract of the leaves of Cassia Siamea Lam. Procedia Computer Science 135 632-642. |
|
|
Vinayagam R, Xu B (2015). Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutrition & Metabolism 12:1-20. |
|
|
Willcox ML, Elugbaju C, Al-Anbaki M, Lown M, Graz B (2021). Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials. Frontiers in Pharmacology 12:1-13. |
|
|
Zang Y, Igarashi K, Li Y (2016). Anti-diabetic effects of luteolin and luteolin-7-O glucoside on KK-A(y) mice. Bioscience, Biotechnology, and Biochemistry 80(8):1580-1886. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
